Lee Josephson
Corporate Officer/Principal at Harvard Medical School
Profile
Lee Josephson is the founder of T2 Biosystems, Inc. (founded in 2006).
He is currently an Associate Professor at Harvard Medical School.
Dr. Josephson previously worked as a Director-Probe Chemistry at The General Hospital Corp.
and as a Principal at the Center for Translational Molecular Medicine.
He received his undergraduate degree from the University of Wisconsin and his doctorate from The State University of New York.
Dr. Josephson is also the founder of AMAG Pharmaceuticals, Inc.
Lee Josephson active positions
| Companies | Position | Start |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 2011-04-06 |
Former positions of Lee Josephson
| Companies | Position | End |
|---|---|---|
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| AMAG PHARMACEUTICALS, INC. | Founder | - |
Center for Translational Molecular Medicine
 Center for Translational Molecular Medicine BiotechnologyHealth Technology The Center for Translational Molecular Medicine provides molecular science research services. The non-profit company is based in Eindhoven, Netherlands. and has subsidiaries in Netherlands. | Corporate Officer/Principal | - |
| T2 BIOSYSTEMS, INC. | Founder | - |
Training of Lee Josephson
| University of Wisconsin | Undergraduate Degree |
| The State University of New York | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| T2 BIOSYSTEMS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Center for Translational Molecular Medicine
Center for Translational Molecular Medicine BiotechnologyHealth Technology The Center for Translational Molecular Medicine provides molecular science research services. The non-profit company is based in Eindhoven, Netherlands. and has subsidiaries in Netherlands. | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
- Stock Market
- Insiders
- Lee Josephson
